FIELD: medicine. SUBSTANCE: invention relates to the use of amperozid or its pharmaceutically acceptable salt by oral or parenteral route at daily dose 0.1-40 mg. Dose is administrated for time depending on syndrome severity. EFFECT: enhanced effectiveness of agent. 3 cl
Authors
Dates
1997-11-10—Published
1992-03-23—Filed